Literature DB >> 7359257

Epidemic influenza myopathy in Cincinnati in 1977.

M K Farrell, J C Partin, K E Bove.   

Abstract

A distinctive myopathy was observed in 24 children following influenza B infection. The abrupt onset of severe muscle pain and difficulty in walking began as the respiratory symptoms were waning. The lower extremities, particularly the gastrocnemius and soleus muscles, were involved preferentially. Nasopharyngeal cultures were positive for influenza B Hong Kong in 18 of these patients. Serum creatine phosphokinase levels were significantly elevated (mean 55.2 units) when compared to controls and nine patients with Reye syndrome. The cardiac muscle isoenzyme was detected in the serum of 17 myopathy patients. Serum glutamic oxaloacetic transaminase, but not serum glutamic pyruvic transaminase, was elevated compared to controls (P less than 0.01) but less (P less than 0.001) than the patients with Reye syndrome. Twelve patients underwent muscle biopsy; segmental rhabdomyolysis without inflammation was detected in nine patients. Myopathy is a complication of influenza infection that can be diagnosed by clinical, biochemical, and virologic examination.

Entities:  

Mesh:

Year:  1980        PMID: 7359257     DOI: 10.1016/s0022-3476(80)80864-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  12 in total

Review 1.  Benign acute childhood myositis in an accident and emergency setting.

Authors:  L M Rennie; N F Hallam; T F Beattie
Journal:  Emerg Med J       Date:  2005-10       Impact factor: 2.740

2.  Benign acute myositis associated with H1N1 influenza A virus infection.

Authors:  Esther Rubín; Luis De la Rubia; Andrea Pascual; Jana Domínguez; Cristina Flores
Journal:  Eur J Pediatr       Date:  2010-03-07       Impact factor: 3.183

3.  Acute transient myositis of childhood.

Authors:  C O'Reilly; D Gill; S Dockeray
Journal:  Ir J Med Sci       Date:  1983-10       Impact factor: 1.568

4.  Acute alterations in the regulation of lipid metabolism after intravascular reexposure to a single bolus of homologous virus during influenza B infection in ferrets: possible model of epiphenomena associated with influenza.

Authors:  E S Kang; M S Galloway; W Bean; G A Cook; G Olson
Journal:  Int J Exp Pathol       Date:  1991-06       Impact factor: 1.925

Review 5.  Diminished immune responses with aging predispose older adults to common and uncommon influenza complications.

Authors:  Spencer R Keilich; Jenna M Bartley; Laura Haynes
Journal:  Cell Immunol       Date:  2019-10-10       Impact factor: 4.868

6.  Genetic characterisation of influenza B viruses detected in Singapore, 2004 to 2009.

Authors:  Muhammad Raihan Jumat; Richard J Sugrue; Boon-Huan Tan
Journal:  BMC Res Notes       Date:  2014-12-01

7.  Aging augments the impact of influenza respiratory tract infection on mobility impairments, muscle-localized inflammation, and muscle atrophy.

Authors:  Jenna M Bartley; Sarah J Pan; Spencer R Keilich; Jacob W Hopkins; Iman M Al-Naggar; George A Kuchel; Laura Haynes
Journal:  Aging (Albany NY)       Date:  2016-04       Impact factor: 5.682

8.  Molecular and biochemical characterization of the NS1 protein of non-cultured influenza B virus strains circulating in Singapore.

Authors:  Muhammad Raihan Jumat; Puisan Wong; Raphael Tze Chuen Lee; Sebastian Maurer-Stroh; Boon Huan Tan; Richard J Sugrue
Journal:  Microb Genom       Date:  2016-08-25

9.  Productive infection of human skeletal muscle cells by pandemic and seasonal influenza A(H1N1) viruses.

Authors:  Marion Desdouits; Sandie Munier; Marie-Christine Prevost; Patricia Jeannin; Gillian Butler-Browne; Simona Ozden; Antoine Gessain; Sylvie Van Der Werf; Nadia Naffakh; Pierre-Emmanuel Ceccaldi
Journal:  PLoS One       Date:  2013-11-05       Impact factor: 3.240

10.  Pediatric influenza-associated myositis - Nebraska, 2001-2007.

Authors:  Bryan F Buss; Vivek M Shinde; Thomas J Safranek; Timothy M Uyeki
Journal:  Influenza Other Respir Viruses       Date:  2009-11       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.